128 related articles for article (PubMed ID: 16917071)
1. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of CYP2A13 polymorphisms.
Schlicht KE; Michno N; Smith BD; Scott EE; Murphy SE
Xenobiotica; 2007 Dec; 37(12):1439-49. PubMed ID: 17922361
[TBL] [Abstract][Full Text] [Related]
3. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of Flp-In
Liu X; He J; Yang C; Wang Y; Xue W; He B; Li Y; Lan Y; Liu T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):865-871. PubMed ID: 31814561
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.
Liu T; Hong Y; Li Z; Hong J; Zeng S; Zheng M; Chen S
Drug Metab Dispos; 2012 May; 40(5):847-51. PubMed ID: 22315333
[TBL] [Abstract][Full Text] [Related]
6. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
[TBL] [Abstract][Full Text] [Related]
7. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract.
He XY; Tang L; Wang SL; Cai QS; Wang JS; Hong JY
Int J Cancer; 2006 Jun; 118(11):2665-71. PubMed ID: 16385575
[TBL] [Abstract][Full Text] [Related]
8. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
Zhu LR; Thomas PE; Lu G; Reuhl KR; Yang GY; Wang LD; Wang SL; Yang CS; He XY; Hong JY
Drug Metab Dispos; 2006 Oct; 34(10):1672-6. PubMed ID: 16815959
[TBL] [Abstract][Full Text] [Related]
9. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Zhang X; D'Agostino J; Wu H; Zhang QY; von Weymarn L; Murphy SE; Ding X
J Pharmacol Exp Ther; 2007 Nov; 323(2):570-8. PubMed ID: 17671098
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Chiang HC; Wang CY; Lee HL; Tsou TC
Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
[TBL] [Abstract][Full Text] [Related]
12. Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen.
He XY; Shen J; Ding X; Lu AY; Hong JY
Drug Metab Dispos; 2004 Dec; 32(12):1516-21. PubMed ID: 15333516
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J; Zhang X; Wu H; Ling G; Wang S; Zhang QY; Liu F; Ding X
Drug Metab Dispos; 2008 Nov; 36(11):2316-23. PubMed ID: 18669584
[TBL] [Abstract][Full Text] [Related]
14. In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10.
Kim V; Yeom S; Lee Y; Park HG; Cho MA; Kim H; Kim D
J Toxicol Environ Health A; 2018; 81(12):493-501. PubMed ID: 29652224
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.
Xiang C; Wang J; Kou X; Chen X; Qin Z; Jiang Y; Sun C; Xu J; Tan W; Jin L; Lin D; He F; Wang H
FASEB J; 2015 May; 29(5):1986-98. PubMed ID: 25667220
[TBL] [Abstract][Full Text] [Related]
19. Human cytochrome p450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine.
Wang SL; He XY; Hong JY
Drug Metab Dispos; 2005 Mar; 33(3):336-40. PubMed ID: 15608128
[TBL] [Abstract][Full Text] [Related]
20. The effects of single nucleotide polymorphisms in CYP2A13 on metabolism of 5-methoxypsoralen.
Goto T; Moriuchi H; Fu X; Ikegawa T; Matsubara T; Chang G; Uno T; Morigaki K; Isshiki K; Imaishi H
Drug Metab Dispos; 2010 Dec; 38(12):2110-6. PubMed ID: 20798279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
